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Purpose. To report outcome data for patients with penile cancer treated surgically with glansectomy and skin grafting. Materials
andMethods.Weretrospectively revieweddataonallpatientsundergoingsurgicalmanagementofpenilecancerbyasinglesurgeon
between 1998 and2008.Outcomesin patients who underwent glansectomyandskingraftingwere analysed.Results. Between 1998
and2008atotalof25 patientswithameanage60(39–83)underwentglansectomyandskingrafting.Sixpatients hadcarcinomain
situ(CIS);thestageintheremainingpatientsrangedfromT1G1 toT3G3.Meanfollowupforpatientswas28months(range6–66).
Disease speciﬁc survival was 92% with 2 patients who had positive nodes at lymph node dissection developing groin recurrence.
One patient developed a local recurrence requiring a partial penectomy. Conclusions. Penile preserving surgery with glansectomy
and skin grafting is a successful technique with minimal complications for local control of penile carcinoma arising on the glans.
Careful followup to exclude local recurrence is required.
1.Introduction
Penile cancer is an uncommon malignancy in the industri-
alized world, particularly in Europe and in the USA with
an incidence of less than 1 per 100000 of the male adult
population. In contrast to this, the incidence in some parts
of the developing world is as high as 19 per 100000 per year
[1].
More than 95% of penile cancers are primary squamous
cell carcinomas with other uncommon histological types
including melanoma, sarcoma, and basal cell carcinomas.
Historically, the surgical management of the primary lesion
in penile carcinoma has meant either partial or radical
penectomy. Oncologically,radical surgical excision has stood
thetestoftime,withexcellentlocalcontrol.Theseoperations
are however often mutilating and associated with urinary
and sexual dysfunction as well as signiﬁcant psychological
morbidity [2].
In an attempt to reduce the negative impact of radical
surgery and retain functional penile length, a variety of
therapeutic strategies have been developed particularly for
the management of more distal lower-grade cancers. The
obvious risk is always that there will be compromise of
local oncological control. Oncological outcomes of “penile
preserving” surgical techniques should always, if possible,
be measured against the gold standard of radical excision.
Randomised trials are next to impossible in such an uncom-
mon disease and although widely practiced and results are
encouraging, only a small number of centres have published
their outcome data on glansectomy and skin grafting for
tumours involving the glans penis.
Herewereport medium-term oncologicalandfunctional
outcomes in a series of patients who underwent glansectomy
andskingraftingforthetreatmentofdistalpenilecarcinoma.
2.Materialsand Methods
We reviewed data on all patients undergoing surgical
management of penile cancer with glansectomy by a single
surgeon at a tertiary referral centre between 1998 and 2008.
All patients had biopsy proven squamous cell carcinoma2 Advances in Urology
Figure 1: Under tourniquet control following an initial standard
circumcision, the glans is detached with sharp dissection exposing
the corporeal heads. The urethra is divided freeing the specimen.
Table 1
G1 (%) G2 (%) G3 (%)
T1 (%) 6 (31%) 7 (37%) 2 (11)
T2 (%) — 1 (5%) 2 (11%)
T3 (%) — — 1 (5%)
or refractory carcinoma in situ and had their primary
tumourclinicallystaged.Latterly,themajorityofthepatients
underwent radiological staging with CT or MRI scan.
Where suitable, glansectomy and split thickness skin
grafting as described by Bracka was performed. The details
of the surgical technique are outlined in Figures 1, 2,
and 3. In summary, under tourniquet control following
an initial standard circumcision the glans is detached with
sharp dissection exposing the corporeal heads. The urethra
is divided and spatulated freeing the specimen. The penile
skin is sutured proximally on to the corporal cavernosa
leavingthecorporalheadsexposedforskingrafting.Apartial
thickness fenestrated skin graft harvested from the medial
thigh is sutured with quilting sutures to the corporeal heads
to form the neoglans. Postoperatively the patient remains in
bed with a catheter in situ for 5 days and the donor graft site
managed in the standard fashion.
The regional nodes were managed dependent on the
clinical and pathological staging of the primary tumour.
Patients were followed up with regular review and clinical
examination.
3.Results
Between 1998 and 2008, a total of 56 patients presenting
with penile cancer underwent surgical treatment. Twenty
ﬁve patients with a mean age of 60 (39–83) underwent
penile preserving surgery with glansectomy and skin grafting
performed by a single surgeon. Six out of 25 patients had
CIS (carcinoma in situ). All the remaining patients had
squamous carcinoma, the grade and stage of which are
summarised in Table 1. Of the remaining 31 patients who
underwent surgery, 26 had either partial or total penectomy
with 4 managed by circumcision alone. Histology was
squamous cell carcinoma in all but two patients who had
melanoma.
Figure 2 :T h ep e n i l es k i ni ss u t u r e dp r o x i m a l l yo nt ot h ec o r p o r a l
cavernosa leaving the corporal heads exposed for skin grafting.
Six of the 25 patients who were treated by glansec-
tomy underwent bilateral modiﬁed groin node dissection
including 2 patients with G3T1, two with G3T2, one
with G3T3, and one patient with G2T1 disease. Of these
patients, three (50%) demonstrated positive nodes. Mean
followup for patients was 28 months (range 10–66). Disease-
speciﬁc survival was 92% with 2 patients who had positive
nodes at groin lymph node dissection developing groin
recurrence. One patient who had G2T1 disease developed
local recurrence requiring partial penectomy.
Nine out of 11 patients evaluated with regards to sexual
functionreportedtheabilitytoachieveerections.Sixpatients
continued to be sexually active, one patient having fathered a
child. There were no graft failures in our series. Two patients
developed a meatal stenosis requiring dilatation; otherwise
no other complications were noted.
4.Discussion
The treatment of uncommon malignancies such as penile
cancer due to the diﬃculty in compiling good quality
evidence-based treatment protocols means that the majority
of the time treatment is based on historical strategies.
Traditionally, the mainstays of treatment were either surgical
amputation ofpart orall ofthepenisorradical radiotherapy.
Surgical removal of a patient’s penis often results in devas-
tating anatomical, functional loss and a major psychological
impact on the patient’s life.
Eighty percent of penile carcinomas occur distally, in-
volving the glans and/or prepuce and are potentially
amenable to organ-preserving surgery. Innovative surgical
techniques have focused on penile preservation in selected
patients to minimize physical disﬁgurement and improve
quality of life for these patients. Published series on the
subject of penile conserving surgery has been limited to a
small number of dedicated centres and leading experts in the
ﬁeld have encouraged reporting ofresults to encouragemore
widespread utilization of these techniques [3].
Very small lesionsof theglans orprepucemay besuitable
for local excision and primary closure or circumcision
alone. Laser therapy with CO2 and neodymium:YAG based
lasers have been used to either excise or ablate tumours or
premalignant lesions such as carcinoma in situ. The results
are satisfactory for premalignant lesions but recurrence ratesAdvances in Urology 3
Figure 3: A partial thickness fenestrated skin graft harvested from
the medial thigh is sutured with quilting sutures to the corporeal
heads to form the neoglans.
of17–33%havebeenreported inthose patientswith invasive
tumours [4–6].
The main factor that perhaps has contributed to the
move toward organ preserving surgery is the realization
that traditional surgical margins of 2cm are unnecessary to
achieve good oncological results. In one series of 51 patients
reportedbyMinhasetal.,only2localrecurrenceswerenoted
with surgical margins in this series, all less than 5mm [7].
Surgical resection margin status has not been recorded in
our series and is a recognised weakness; however, only one
local recurrence in 25 patients has been noted at 28 months
followup. Of note, frozen section at the time of surgery is
now recommended with identiﬁed positive margins treated
by wide local excision, a practice that we have now adopted.
The main types of penile preserving surgery that are cur-
rently in widespread use are partial or total glans resurfacing
or glansectomy followed by skin grafting [8]. Other surgical
techniques such as Mohs micrographic surgery (MMS),
which involves removing the cancer by excising thin layers
of tissue and examining them microscopically, have been
described. Reported experience in this technique is very
limited with only a small number of series published in the
literature. It is a time-consuming procedure which appears
frequently to require multiple treatments, and it is unclear
w h e t h e ri ti sat e c h n i q u et h a ti ss t i l lp r a c t i c e da tt h i st i m e
[9, 10].
The early reporting of glansectomy on small numbers of
patients demonstrated satisfactory outcomes with minimal
complications and low recurrence rates in patients with
malignantandnonmalignant conditions[11,12].Thelargest
published series was a prospective study on 72 patients
who underwent glansectomy with reconstruction for glans-
conﬁned penile squamous cell cancer. Local disease control
was reported as excellent, with a 6% recurrence rate,
despite 24 patients (33%) having high-grade tumours and
37 (51%) with T2 disease [13]. In our series, we have
described 25 patients who underwent glansectomy and skin
grafting with good cosmetic results and local control. Mean
followup was 28 months with one patient developing local
recurrence.
Although the retrospective nature of our study is a
recognised weakness, all the procedures were performed by
a single surgeon and satisfactory medium-term follow-up
results have been achieved.
With regards to oncological control, penile preserving
surgery compares favourably with results for radiotherapy,
theothermainstay ofpenilecancertreatmentthatpotentially
allows for penile preservation. Although well-tolerated,
recurrence ratesofaround 40%havebeenreported forexter-
nal beam radiotherapy [14]. This compares unfavourably
with the data from our series which had only 1 local
recurrence (5%) which mirrors other larger reported series
for penile preserving surgery which have demonstrated
local recurrence rates of 2–4% [13, 15–17]. Brachytherapy
would appear to achieve superior local control to external
beam radiotherapy at 5 year followup achieving penile
preservation in nearly 90% of patients. However, at 10 years
this falls to 67% [18]. In the longer term meatal stenosis,
urethral stricture disease and radiation necrosis are not
infrequent complications of radiotherapy treatment which
may necessitate more radical surgery [13]. Despite these
problemsradiotherapy remains an option formore proximal
disease or in elderly patients unﬁt for anaesthesia.
Complication rates following penile preserving surgery
with either resurfacing or glansectomy are extremely low.
Reported rates of early graft loss following both resurfacing
and glansectomy procedures requiring regrafting are low
ranging from 3–10% [13, 17, 19]. None of the patients
in our series required regrafting. One patient (5%) in our
series suﬀered from meatal stenosis requiring self dilatation
which mirrors the ﬁndings in some of the other reported
series [13, 17]. Following grafting, the majority of authors
advise strict patient immobilization to allow the skin graft
to “take”. A potential improvement in the technique recently
describedinvolvesleavingaproﬂavine-soakedgauzedressing
“tied-over” the graft instead of using quilting sutures to
ﬁx the graft to corporeal heads. This has allowed almost
immediate postoperative mobilization of the patient instead
of the usual 4-5 days strict bed rest. In a reported series using
this technique, only one patient out of 29 patients treated in
this way required regrafting [19].
O n eo ft h em a i na d v a n t a g e so ft h ep e n i l ep r e s e r v i n g
techniques is the potential for preservation of sexual func-
tion. One systematic review examining patient quality of
life postsurgery for penile cancer demonstrated a negative
eﬀectsonwell-beinginupto40%withpsychiatricsymptoms
in approximately 50% of patients. Up to two thirds of
patients also reported a reduction in sexual function [2].
Another study demonstrated that, when asked, some men
would even risk lower long-term survival to increase the
chance of retaining sexual potency [20]. Preservation of
sexual function following penile preserving surgery has been
inconsistently reported in the published literature and none
of the published series including ours have yet included val-
idated tools or questionaires for evaluating sexual function.
In two separate series of 17 patients treated by total or partial
glansectomy with skin grafting, all patients were reported
to maintain sexual function and activity postoperatively
[15, 17]. In our series, only 11 patients were contactable
to evaluate sexual function, 9 of whom could still achieve
erections and 6 remaining sexually active. One explanation
could be an older group of patients in our series (mean age
60 compared to 51 and 53). The prospective collection of4 Advances in Urology
data on sexual function pre- and postoperatively should be
encouraged and is underway in a number of centres engaged
in penile preserving surgery [21].
5.Conclusions
Penile amputation should be considered overtreatment in
the vast majority of patients with penile cancer conﬁned to
the glans penis. Glans reconstruction with or without skin
grafting has proven to be a successful technique with good
follow-up data to support its use. Eﬀorts to preserve penile
lengthandfunctioninthesurgicaltreatment ofpenilecancer
should be made in all suitable patients and there is good
evidence to support this practice.
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